Dyspnea News and Research

RSS

Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Blood pressure control with Clevidipine

Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.

30 Mar 2007

Chronic cough and phlegm means greater risk of developing chronic obstructive pulmonary disease

Young adults (ages 20 to 44) with normal lung function who later develop chronic cough and phlegm have a fourfold higher risk of developing chronic obstructive pulmonary disease (COPD).

2 Jan 2007

Trastuzumab results promising for HER-2 positive breast cancer patients

Researchers have shown that patients who receive trastuzumab at the same time as post-chemotherapy radiation treatments for HER-2 positive breast cancer have no more risk for major side effects or complications than those who do not receive the drug.

7 Jun 2006

Study helps explain why aerobic training helps heart failure patients

Aerobic training is associated with a reversal of abnormal hormonal patterns that underlie many of the debilitating symptoms of heart failure, according to a new study in the Journal of the American College of Cardiology.

3 May 2006

Abdominal fat more significant than overall weight in exercise-induced shortness of breath

When it comes to being short of breath during exercise, how fat is distributed on the body is a more significant factor than overall body fatness or lung function

7 Apr 2006

Phase II clinical study of ularitide

The European Society of Cardiology (ESC) today highlighted results of a Phase II clinical study of ularitide, a synthetic form of a natriuretic peptide synthesized in the kidney for patients with acute decompensated congestive heart failure (ADHF).

5 Sep 2005

Advice to cardiac patients regarding sports and exercise

Increased levels of physical activity are known today to be one of the most powerful protective factors against cardiovascular disease and its progression.

5 Sep 2005

Promising results from study of Pirfenidone in idiopathic pulmonary fibrosis (IPF) patients

InterMune today announced that the American Journal of Respiratory and Critical Care Medicine (AJRCCM) published results from a double-blind, randomized, placebo-controlled Phase II trial evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).

2 May 2005

Exercise-induced shortness of breath not always caused by asthma

Asthma is the most common cause of exercise-induced shortness of breath in children and adolescents. While a diagnosis of asthma is often correct, University of Iowa pediatric pulmonary physicians caution that other unrelated conditions also can cause shortness of breath during exercise.

3 Apr 2005

Lighter air more than doubles COPD patients’ endurance

It certainly makes sense: COPD sufferers have varying degrees of serious breathing difficulties, which keeps them from almost any kind of exercise, especially in advanced stages. So maybe “lighter than air” air would be easier to breath, reduce shortness of breath and perhaps even allow them to do some exercise with all of its physical and mental benefits.

29 Nov 2004

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

1 Nov 2004

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Examination of reports from the first two years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a study in the October 13 issue of JAMA.

12 Oct 2004

Respiratory therapists are at an increased risk of developing asthma

Respiratory therapists are at an increased risk of developing asthma and asthma-related symptoms due to their involvement in the diagnosis and treatment of patients with respiratory conditions.

11 Oct 2004

New statement published on nonmalignant diseases related to asbestos exposure

In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled “Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos.”

4 Oct 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Oral sildenafil improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension

Oral sildenafil (Viagra®) improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension, according to the results of the first randomized, placebo-controlled, double-blind, crossover study, reported in the April 7, 2004 issue of the Journal of the American College of Cardiology.

6 Apr 2004